Literature DB >> 21093331

Clinical spectrum of pediatric blepharokeratoconjunctivitis.

Noopur Gupta1, Anuradha Dhawan, Sarita Beri, Pamela D'souza.   

Abstract

PURPOSE: To evaluate the incidence, symptoms, clinical signs, and therapy instituted in children with blepharokeratoconjunctivitis (BKC).
METHODS: In this observational, retrospective case series, we reviewed all medical records of pediatric patients presenting to the ophthalmology clinic at the Kalawati Saran Children's Hospital, New Delhi, India from 2003 to 2006. History, clinical characteristics, and treatment protocol were noted, as well as reason for presentation/referral and subsequent diagnosis.
RESULTS: Of 5,012 pediatric patients, 615 (12%) demonstrated features of BKC. Boys were more commonly affected (62%) than girls. The mean age at presentation was 6.7 years (range, 7 months to 16 years). Lid involvement and conjunctival congestion were consistent features. Anterior (seborrheic variety) blepharitis was seen in nearly half the children (302), followed by chalazion (18%), external hordeolum (17%), ulcerative anterior blepharitis (6%), phlyctenular keratoconjunctivitis (6%), and marginal ulcerative keratitis (2%). Refractive error was evident in 521 of 615 children (85%) with BKC. All patients were treated with daily eyelid hygiene, warm compresses, and topical antibiotics. Corticosteroid drops were prescribed in 14% and oral erythromycin in 23%.
CONCLUSIONS: BKC was the commonest diagnosis at consultation among all pediatric referrals. Anterior blepharitis was more common than posterior blepharitis. Severe cases with corneal involvement accounted for only 5% of the disease spectrum.
Copyright © 2010 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21093331     DOI: 10.1016/j.jaapos.2010.09.013

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  7 in total

Review 1.  Topical treatments for blepharokeratoconjunctivitis in children.

Authors:  Michael O'Gallagher; Catey Bunce; Melanie Hingorani; Frank Larkin; Stephen Tuft; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2017-02-07

2.  Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome.

Authors:  A Rodríguez-García; S González-Godínez; S López-Rubio
Journal:  Eye (Lond)       Date:  2015-12-04       Impact factor: 3.775

Review 3.  Systemic treatment for blepharokeratoconjunctivitis in children.

Authors:  Michael O'Gallagher; Marina Banteka; Catey Bunce; Frank Larkin; Stephen Tuft; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2016-05-30

4.  Phlyctenular keratoconjunctivitis among children in the tertiary eye hospital of Kathmandu, Nepal.

Authors:  Pragati Gautam; Gauri Shankar Shrestha; Ananda Kumar Sharma
Journal:  Oman J Ophthalmol       Date:  2015 Sep-Dec

5.  Demodex blepharokeratoconjunctivitis affecting young patients: A case series.

Authors:  Nikunj Vinodbhai Patel; Umang Mathur; Arpan Gandhi; Manisha Singh
Journal:  Indian J Ophthalmol       Date:  2020-05       Impact factor: 1.848

6.  Evaluation of the ocular surface characteristics and Demodex infestation in paediatric and adult blepharokeratoconjunctivitis.

Authors:  Mengliang Wu; Xiaochun Wang; Jing Han; Tingting Shao; Yan Wang
Journal:  BMC Ophthalmol       Date:  2019-03-07       Impact factor: 2.209

7.  Topical cyclosporin as an alternative treatment for vision threatening blepharokeratoconjunctivitis: a case report.

Authors:  Abdul-Salim Ismail; Rohana Taharin; Zunaina Embong
Journal:  Int Med Case Rep J       Date:  2012-06-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.